Interferon/Ribavirin-Free Sofosbuvir Based Treatment Regimens In Patients With Advanced Liver Disease - Results Of A Real-Life Austrian Ribavirin-/Interferon Free Cohort (AURIC)
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Daclatasvir/sofosbuvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatic fibrosis; Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- Acronyms AURIC
- 04 Sep 2017 New trial record
- 02 Sep 2017 Status changed from recruiting to completed.